Disease-modifying pathways in neurodegeneration.
نویسندگان
چکیده
Steven Finkbeiner,1,2,3 Ana Maria Cuervo,5 Richard I. Morimoto,6 and Paul J. Muchowski1,3,4 1Gladstone Institute of Neurological Disease and Departments of 2Physiology, 3Neurology, and 4Biochemistry and Biophysics, University of California, San Francisco, San Francisco, California 94158, 5Department of Anatomy and Structural Biology, Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, and 6Department of Biochemistry, Molecular Biology, and Cell Biology, Rice Institute for Biomedical Research, Northwestern University, Evanston, Illinois 60208
منابع مشابه
P 133: Neuroinflammation in Alzheimer ’s Disease
Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common form of dementia. Almost 47 million people suffer from dementia worldwide. AD accounts for approximately 60%–80% of all dementia cases. Three major pathologies characterize the disease: senile plaques, neurofibrillary tangles and inflammation. We review the literature on events contributing to the inflammat...
متن کاملGlobal gene expression analysis using microarray to study differential vulnerability to neurodegeneration
Neurodegenerative disorders such as Parkinson’s disease, motor neuron disease and Alzheimer’s disease is characterized by loss of specific cells within certain regions of the brain. One of the most compelling questions is to determine why specific cell populations are vulnerable to neurodegeneration. We addressed this question by studying global gene expression changes using an animal model of ...
متن کاملDuloxetine by Modulating the Akt/GSK3 Signaling Pathways Has Neuroprotective Effects against Methamphetamine-Induced Neurodegeneration and Cognition Impairment in Rats
Background: The neuroprotective effects of duloxetine, as an antidepressant agent, and the neurodegenerative effects of methamphetamine have been shown in previous studies. Nonetheless, their exact neurochemical and behavioral effects are still unclear. In the current study, we sought to clarify the molecular mechanisms involved in the protective effects of duloxetine against methamphetamine-in...
متن کاملPharmacological evidence for lithium-induced neuroprotection against methamphetamine-induced neurodegeneration via Akt-1/GSK3 and CREB-BDNF signaling pathways
Objective(s): Neurodegeneration is an outcome of Methamphetamine (METH) abuse. Studies have emphasized on the neuroprotective properties of lithium. The current study is designed towards evaluating the role of Akt-1/GSK3 and CREB-BDNF signaling pathways in mediating lithium neuroprotection against METH-induced neurodegeneration in rats. Materials and ...
متن کاملNanotechnology Building Blocks for Intervention with Alzheimer’s Disease Pathology: Implications in Disease Modifying Strategies
Alzheimer’s disease (AD) is the most common neurodegenerative disorder manifested by progressive loss of memory followed by irreversible dementia [1-3]. AD neurodegeneration is characterized by the loss of neurons preceded by cell membrane and cytoskeleton damage due to a complex of molecular pathways that finally lead to formation of amyloid-β (Aβ) plaques and neurofibrillary tangles in the br...
متن کاملNanotechnology Building Blocks for Intervention with Alzheimer’s Disease Pathology: Implications in Disease Modifying Strategies
Alzheimer’s disease (AD) is the most common neurodegenerative disorder manifested by progressive loss of memory followed by irreversible dementia [1-3]. AD neurodegeneration is characterized by the loss of neurons preceded by cell membrane and cytoskeleton damage due to a complex of molecular pathways that finally lead to formation of amyloid-β (Aβ) plaques and neurofibrillary tangles in the br...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The Journal of neuroscience : the official journal of the Society for Neuroscience
دوره 26 41 شماره
صفحات -
تاریخ انتشار 2006